Mar. 14, 2007 — Acrongenomics, Inc., Geneva, Switzerland, and Molecular Vision, Ltd. (MLV), a spin-out company of Imperial College in London, England, say they’ve made a successful demonstration of their BioLED Lab on a Chip in a high sensitivity, small size, medical diagnostic device. The lab-on-a-chip unit, which uses MVL’s patented, organic semiconductor technology, proved its capability to measure biomarkers with high sensitivity and at low cost.
BioLED technology uses semiconductor films located on either side of a microfluidics chip. One film illuminates the chip, where appropriate, while the other film detects an output signal, which is fed to a display. The demonstrated device used two forms of detection utilizing chemiluminescence and fluorescence to detect different markers of interest.
Acrongenomics and MLV believe that this technology is capable of further miniaturization along with large scale, low cost manufacturing, which will bring forward disposable, point-of-care diagnostics for a large range of biomarkers.